I. Basic Information on Routine Related Transactions
(1) Review Procedures for Routine Related Transactions
-
Board Review and Related Director Abstention On April 17, 2026, the company held the 14th meeting of the third board of directors, which approved the proposal regarding the confirmation of routine related transactions for 2025 and the estimation for 2026. Related directors Yu Feng, Ye Yanliu, Cheng Dongfang, and You Xingquan abstained from voting, while the remaining non-related directors unanimously agreed to the proposal.
-
Independent Directors' Special Meeting Review On April 17, 2026, the company held its first special meeting of independent directors for 2026, which approved the aforementioned proposal. The independent directors stated that the routine related transactions that occurred in 2025 and those estimated for 2026 were based on the company's actual operational needs, adhered to principles of fairness, justice, and openness, had reasonable pricing, and did not affect the company's independence or harm the interests of the company and all shareholders, especially minority shareholders. Given that the estimated amounts for routine related transactions are based on the upper limits of potential business, actual amounts will be determined by the final contract amounts, which carry significant uncertainty. Therefore, discrepancies between actual occurrences and estimates are normal and will not significantly impact the company's daily operations and performance. All independent directors unanimously agreed to the proposal and consented to submit it to the board for review.
-
This proposal still requires submission to the shareholders' meeting for review, with related shareholders needing to abstain from voting.
(2) Estimated and Executed Routine Related Transactions for 2025
-
Related Transactions for Purchase and Sale of Goods, Provision and Acceptance of Services | Related Party | Transaction Type | Specific Content | Actual Amount for 2025 | Estimated Amount for 2025 | Actual Amount as Percentage of Similar Business (%) | Difference Between Actual and Estimated Amount (%) | |---------------|------------------|------------------|------------------------|---------------------------|----------------------------------------------------|---------------------------------------------------| | Jianfa Group and its subsidiaries | Purchase of Goods | Medical Equipment Purchase | 63.15 | 500.00 | 0.00 | -87.37 | | | Acceptance of Services | Warehousing and Logistics Services | 889.13 | 1,500.00 | 0.05 | -40.72 | | | Other Miscellaneous Purchases | Daily Office Expenses, etc. | 681.28 | 1,000.00 | 0.04 | -31.87 | | Total | | | 1,633.56 | 3,000.00 | 0.09 | -45.55 |
-
Sales of Goods and Provision of Services | Related Party | Transaction Type | Specific Content | Actual Amount for 2025 | Estimated Amount for 2025 | Actual Amount as Percentage of Similar Business (%) | Difference Between Actual and Estimated Amount (%) | |---------------|------------------|------------------|------------------------|---------------------------|----------------------------------------------------|---------------------------------------------------| | Jianfa Group and its subsidiaries | Sale of Goods | Medical Equipment Sale | 1,043.33 | 2,000.00 | 0.05 | -47.83 | | Total | | | 1,043.33 | 2,000.00 | 0.05 | -47.83 |